tirzepatide cause high blood pressure GLP-1 medications are rewriting the rules of cardiovascular medicine. A landmark meta-analysis of 99,599 patients found: ✓ 20% reduction in major cardiovascular events ✓ 12% reduction in all-cause death ✓ 15% reduction Understanding Tirzepatide Side Effects, Risks

Always disclose kidney or liver conditions to PlexusDx before starting treatment

Weight loss of this magnitude independently improves lipid profiles, but it does not eliminate the need for statin therapy in patients who meet ASCVD risk thresholds

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context on your individual predispositions in key GLP-1 signaling and metabolic pathways

Policy This is the first study to evaluate and demonstrate a possible protective association between GLP-1 therapy and risk of uveitis, says senior author Sumit Sharma, MD, a vitreoretinal surgeon and uveitis specialist at Cleveland Clinic Cole Eye Institute

5 Conclusion This study systematically analyzed data from the FAERS database, covering from Q1 2004 to Q2 2024, to investigate reports of cholecystitis and cholelithiasis in which GLP-1 RAs were identified as the primary suspect drug